Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer.
lipolysis
localized prostate cancer
periprostatic adipose tissue
prostate cancer
subcutaneous adipose tissue
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
28 May 2020
28 May 2020
Historique:
received:
25
04
2020
revised:
21
05
2020
accepted:
27
05
2020
entrez:
3
6
2020
pubmed:
3
6
2020
medline:
3
6
2020
Statut:
epublish
Résumé
The prostate is surrounded by periprostatic adipose tissue (PPAT), the thickness of which has been associated with more aggressive prostate cancer (PCa). There are limited data regarding the functional characteristics of PPAT, how it compares to subcutaneous adipose tissue (SAT), and whether in a setting of localized PCa, these traits are altered by obesity or disease aggressiveness. PPAT and SAT were collected from 60 men (age: 42-78 years, BMI: 21.3-35.6 kg/m
Identifiants
pubmed: 32481537
pii: cancers12061385
doi: 10.3390/cancers12061385
pmc: PMC7352157
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Movember Foundation
ID : MRTA3
Organisme : University of Sydney
ID : Robinson Fellowship
Organisme : Sydney Medical School Foundation
ID : Hoy
Organisme : Cancer Council South Australia
ID : Beat Cancer Project Butler
Organisme : Department of Health and Ageing, Australian Government
ID : APCRC-NSW
Organisme : Cancer Institute NSW
ID : APCRC-NSW
Organisme : Prostate Cancer Foundation of Australia
ID : MRTA3
Références
Endocr Connect. 2015 Dec;4(4):R68-80
pubmed: 26581226
Am J Surg Pathol. 1990 Mar;14(3):240-7
pubmed: 2305930
Cancer Metastasis Rev. 1989 Aug;8(2):98-101
pubmed: 2673568
J Urol. 2009 Oct;182(4):1621-7
pubmed: 19683746
Curr Obes Rep. 2017 Jun;6(2):195-203
pubmed: 28434109
Prostate Int. 2016 Mar;4(1):1-6
pubmed: 27014656
Nat Commun. 2017 May 23;8:15253
pubmed: 28534500
Biochim Biophys Acta. 2013 Oct;1831(10):1518-32
pubmed: 23562839
Prostate Cancer Prostatic Dis. 2016 Jun;19(2):122-31
pubmed: 26754262
J Magn Reson Imaging. 2015 Sep;42(3):651-7
pubmed: 25522916
J Steroid Biochem Mol Biol. 2014 Sep;143:277-84
pubmed: 24787657
Andrology. 2017 May;5(3):511-515
pubmed: 28296186
J Lipid Res. 1986 Jan;27(1):114-20
pubmed: 3958609
Cell Physiol Biochem. 2012;30(1):113-22
pubmed: 22759960
Oncol Lett. 2015 Mar;9(3):1307-1312
pubmed: 25663903
Oncotarget. 2016 Jul 26;7(30):47650-47662
pubmed: 27351281
Integr Cancer Ther. 2017 Mar;16(1):32-62
pubmed: 27365385
Cold Spring Harb Perspect Med. 2018 Dec 3;8(12):
pubmed: 29530945
Nat Rev Endocrinol. 2019 Mar;15(3):139-154
pubmed: 30459447
Diabetes. 1983 Feb;32(2):117-23
pubmed: 6337893
Nat Commun. 2016 Jan 12;7:10230
pubmed: 26756352
J Natl Cancer Inst. 1997 Mar 5;89(5):385-9
pubmed: 9060961
Prostate. 2006 Nov 1;66(15):1664-73
pubmed: 16902972
Aging Male. 2019 Dec;22(4):228-240
pubmed: 30354924
BMC Med. 2012 Sep 25;10:108
pubmed: 23009291
PLoS One. 2013 Oct 02;8(10):e74927
pubmed: 24098359
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2936-42
pubmed: 25261967
Arch Intern Med. 2010 Aug 9;170(15):1293-301
pubmed: 20696950
PLoS One. 2014 Sep 03;9(9):e106677
pubmed: 25184215
BMC Med. 2017 Jul 13;15(1):115
pubmed: 28701188
Urol Oncol. 2015 Nov;33(11):494.e1-7
pubmed: 26278366
Biochem Soc Trans. 2005 Apr;33(Pt 2):423-7
pubmed: 15787620
Cancer. 1972 Jul;30(1):5-13
pubmed: 5064808
PLoS One. 2012;7(5):e36569
pubmed: 22574183
AJR Am J Roentgenol. 2015 Jan;204(1):W43-7
pubmed: 25539273
Sci Rep. 2016 May 26;6:26791
pubmed: 27225296
Obes Res. 2004 Jan;12(1):95-105
pubmed: 14742847
Prostate. 2014 Feb;74(3):326-35
pubmed: 24571013
Nat Commun. 2016 May 31;7:11674
pubmed: 27241286
Adipocyte. 2015 Apr 01;4(4):273-9
pubmed: 26451283
Trends Endocrinol Metab. 2014 May;25(5):255-62
pubmed: 24731595
Int J Obes (Lond). 2008 Oct;32(10):1595-605
pubmed: 18725890
Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E958-64
pubmed: 17609260
Prostaglandins Leukot Essent Fatty Acids. 2002 May-Jun;66(5-6):467-77
pubmed: 12144866
Int J Cancer. 2016 Mar 15;138(6):1388-400
pubmed: 26488767
Endocr Relat Cancer. 2012 Sep 05;19(5):F47-62
pubmed: 22514110
J Clin Oncol. 1994 Nov;12(11):2254-63
pubmed: 7964940
Mayo Clin Proc. 2014 Mar;89(3):335-45
pubmed: 24582192
Am J Surg Pathol. 1996 Mar;20(3):286-92
pubmed: 8772781
Nutrients. 2019 Apr 26;11(5):
pubmed: 31035457
BJU Int. 2017 Nov;120(5):651-658
pubmed: 28371244
Obes Rev. 2010 Jan;11(1):11-8
pubmed: 19656312
Biomed Res Int. 2015;2015:274585
pubmed: 25866768
Int J Urol. 2010 Apr;17(4):369-76
pubmed: 20409231
Cell Physiol Biochem. 2012;29(1-2):233-40
pubmed: 22415092
N Engl J Med. 2008 Nov 13;359(20):2105-20
pubmed: 19005195
Ann Med. 1995 Aug;27(4):435-8
pubmed: 8519504
Annu Rev Nutr. 2007;27:79-101
pubmed: 17313320
Endocr Relat Cancer. 2015 Dec;22(6):R365-86
pubmed: 26373570
J Lipid Res. 2012 Dec;53(12):2791-6
pubmed: 22993232
Cancer. 1999 Nov 1;86(9):1775-82
pubmed: 10547551
World J Urol. 2010 Dec;28(6):699-704
pubmed: 20033185
J Exp Clin Cancer Res. 2012 Apr 02;31:32
pubmed: 22469146
BJU Int. 2011 Jun;107(11):1775-9
pubmed: 21050356
Int J Epidemiol. 2012 Jun;41(3):805-17
pubmed: 22467292
J Clin Endocrinol Metab. 1997 Dec;82(12):4162-6
pubmed: 9398732
Eur J Cancer. 2018 Mar;91:107-115
pubmed: 29413967
BJU Int. 2018 May;121 Suppl 3:9-21
pubmed: 29460324
J Biol Chem. 2014 Jan 24;289(4):1905-16
pubmed: 24302733
Prostate Cancer Prostatic Dis. 2017 Dec;20(4):418-423
pubmed: 28653675
Urol J. 2014 Sep 06;11(4):1793-9
pubmed: 25194078
Cancer. 1994 Apr 1;73(7):1904-12
pubmed: 7511040
Mol Cancer Res. 2019 Mar;17(3):821-835
pubmed: 30606769
Int J Cancer. 2017 Jun 15;140(12):2657-2666
pubmed: 28268252
Biochem Soc Symp. 1978;(43):97-135
pubmed: 219867
J Urol. 2013 Dec;190(6):2061-6
pubmed: 23820055
JAMA. 2010 Jan 20;303(3):250-7
pubmed: 20085953
Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G1-4
pubmed: 17218471
Soz Praventivmed. 2003;48(3):191-200
pubmed: 12891871